Pharma Industry News Weekly Recap: September 15, 2023
// Biotech and Pharma Therapeutics AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology September [...]
// Biotech and Pharma Therapeutics AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology September [...]
// Biotech and Pharma Therapeutics Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window' [...]
// Biotech and Pharma Therapeutics Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover July [...]
// Biotech and Pharma Therapeutics Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for [...]
// Biotech and Pharma Therapeutics Expanding Access to Women’s Health Fresenius Kabi Launches Generic Fertility Treatment July 10, [...]
// Biotech and Pharma Therapeutics Atea rejects takeover bid from Concentra May 30, 2023 / Atea / Concentra [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May [...]
// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May [...]
// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA [...]